Jubilant Pharmova Limited ('Company') today announced that the United States Food and Drug Administration (USFDA) has concluded the audit of the Jubilant HollisterStier General Partnership ("JHSGP")'s contract manufacturing facility located in Montreal, Canada. The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations.
JHSGP is a subsidiary of Jubilant HollisterStier Inc., USA, a step down subsidiary of Jubilant Pharma Limited, Singapore, and a wholly owned subsidiary of the Company.
Shares of Jubilant Pharmova Limited was last trading in BSE at Rs. 754.40 as compared to the previous close of Rs. 747.40. The total number of shares traded during the day was 17857 in over 1987 trades.
The stock hit an intraday high of Rs. 763.75 and intraday low of 741.65. The net turnover during the day was Rs. 13496728.00. |